Loading…

Primary papillary carcinoma of the peritoneum: analysis of putative target molecules (COX-2, HER-2/neu Steroid -hormone receptors)

Purpose: Primary peritoneal carcinomas (PPC) are rare but aggressive malignancies. Evaluating therapeutic relevant molecules PPC were investigated immunohistochemically. Methods: 26 PPC were stained with antibodies against estrogen and progesterone receptors, HER-2/neu and COX-2 with semiquantitativ...

Full description

Saved in:
Bibliographic Details
Main Authors: Horn, LC, Purz, S, Einenkel, J
Format: Conference Proceeding
Language:eng ; ger
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: Primary peritoneal carcinomas (PPC) are rare but aggressive malignancies. Evaluating therapeutic relevant molecules PPC were investigated immunohistochemically. Methods: 26 PPC were stained with antibodies against estrogen and progesterone receptors, HER-2/neu and COX-2 with semiquantitative evaluation of the staining results. Results: Twentyone out of the 26 PPC (80;8%) were negative or showed only weak expression for estrogen receptor. One half of the tumors showed moderate or strong positivity for progesterone receptor. Only three PPC (11;5%) showed strong immunoreaction for HER-2/neu (Score 3). Nearly two thirds of the PPC represented COX-2 overexpression. Conclusions: PPCs are probably not under hormonal control of estrogens and lack HER-2/neu overexpression in the majority of cases. So, anti-hormonal or antibody therapy with herceptine is not indicated. The use of COX-2 inhibitores might be helpful in PPC.
ISSN:0016-5751
1438-8804
DOI:10.1055/s-0029-1238970